Annexin-A1: The culprit or the solution?

Kelly, Lauren; McGrath, Sarah; Rodgers, Lewis; McCall, Kathryn; Tulunay Virlan, Aysin; Dempsey, Fiona; Crichton, Scott; Goodyear, Carl S

Kelly, Lauren; McGrath, Sarah; Rodgers, Lewis; McCall, Kathryn; Tulunay Virlan, Aysin; Dempsey, Fiona; Crichton, Scott; Goodyear, Carl S.

Afiliación

Kelly L; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
McGrath S; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
Rodgers L; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
McCall K; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
Tulunay Virlan A; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
Dempsey F; Medannex Ltd, Fountainbridge, Edinburgh, UK.
Crichton S; Medannex Ltd, Fountainbridge, Edinburgh, UK.
Goodyear CS; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.

Immunology ; 166(1): 2-16, 2022 05.

Article en En | MEDLINE | ID: mdl-35146757

Asunto(s)

Anexina A1; Inmunidad Adaptativa; Animales; Anexina A1/metabolismo; Antiinflamatorios; Humanos; Inflamación; Ratones; Receptores de Formil Péptido/metabolismo; Linfocitos T/metabolismo

Palabras clave

Annexin-A1; biomarker; cancer; cell signalling inflammation; formyl peptide receptors; immune response

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anexina A1 Límite: Animals / Humans Idioma: En Revista: Immunology Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google